CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[CELMoD Mechanism and Differentiation From IMiDs in Multiple Myeloma]]>

ConferenceCELMoDIMiDsNeutral
AI Analysis

Summary

Educational discussion on CELMoD mechanism of action, explaining how CELMoDs engage the cereblon E3 ubiquitin ligase complex to promote degradation of Ikaros and Aiolos transcription factors in multiple myeloma cell biology, differentiating them from IMiDs.

Importance:2/10
Sentiment:
0.00
Multiple MyelomaCELMoDIMiDsCereblonMechanism of ActionEducational Content

Read the original article

Published by Cancer Network on August 28, 2026 12:15 PM

Read Original